Elsken van der Wall Selected Research

Drug Therapy (Chemotherapy)

1/2022	Physical Fitness and Chemotherapy Tolerance in Patients with Early-Stage Breast Cancer.
11/2021	Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients.
2/2021	Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer.
11/2020	Phase I feasibility study of Magnetic Resonance guided High Intensity Focused Ultrasound-induced hyperthermia, Lyso-Thermosensitive Liposomal Doxorubicin and cyclophosphamide in de novo stage IV breast cancer patients: study protocol of the i-GO study.
1/2020	High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical Trial.
1/2020	Long-Term Favorable Effects of Physical Exercise on Burdensome Symptoms in the OptiTrain Breast Cancer Randomized Controlled Trial.
1/2019	Effect of physical exercise on cognitive function and brain measures after chemotherapy in patients with breast cancer (PAM study): protocol of a randomised controlled trial.
1/2017	Cost-effectiveness analysis of an 18-week exercise programme for patients with breast and colon cancer undergoing adjuvant chemotherapy: the randomised PACT study.
1/2012	Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.
4/2011	Cancer-related fatigue: clinical practice versus practice guidelines.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Elsken van der Wall Research Topics

Disease

67	Neoplasms (Cancer) 01/2022 - 03/2003
60	Breast Neoplasms (Breast Cancer) 06/2022 - 03/2003
17	Hypoxia (Hypoxemia) 01/2016 - 02/2003
12	Neoplasm Metastasis (Metastasis) 01/2018 - 03/2003
9	Carcinogenesis 01/2022 - 04/2006
7	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2020 - 01/2013
4	Fatigue 01/2020 - 11/2005
3	Male Breast Neoplasms (Male Breast Cancer) 01/2015 - 01/2013
2	Triple Negative Breast Neoplasms 01/2022 - 03/2017
2	Inflammation (Inflammations) 04/2018 - 10/2009
2	Prostatic Neoplasms (Prostate Cancer) 09/2013 - 05/2013
2	Necrosis 07/2013 - 12/2007
2	Phyllodes Tumor (Cystosarcoma Phylloides) 05/2005 - 01/2005
1	Amenorrhea 11/2021
1	Hyperthermia 11/2020
1	Muscular Atrophy (Muscle Atrophy) 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Atrophy 01/2020
1	Syndrome (Syndromes) 01/2020
1	Cardiotoxicity 01/2018
1	Colonic Neoplasms (Colon Cancer) 01/2017
1	Lobular Carcinoma 12/2016
1	Colorectal Neoplasms (Colorectal Cancer) 09/2015
1	Lung Neoplasms (Lung Cancer) 05/2015
1	Breast Diseases (Breast Disease) 11/2013

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2015 - 02/2003
12	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2008
11	Transcription Factors (Transcription Factor)IBA 12/2018 - 03/2003
8	Estrogen ReceptorsIBA 01/2022 - 03/2003
5	SDMIBA 01/2022 - 01/2020
5	ParaffinIBA 10/2019 - 12/2003
5	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 12/2005
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 03/2003
5	Carbonic Anhydrase IXIBA 11/2013 - 01/2005
4	Hormones (Hormone)IBA 01/2022 - 08/2014
4	RNA Helicases (RNA Helicase)IBA 10/2021 - 01/2013
4	human ERBB2 proteinIBA 02/2021 - 01/2010
4	Oxygen (Dioxygen)IBA 12/2012 - 12/2005
3	MicroRNAs (MicroRNA)IBA 12/2021 - 11/2019
3	Trastuzumab (Herceptin)FDA Link 02/2021 - 01/2010
3	AnthracyclinesIBA 01/2018 - 01/2010
3	Cadherins (E-Cadherin)IBA 12/2016 - 01/2009
3	Glucose (Dextrose)FDA LinkGeneric 11/2013 - 05/2003
3	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013 - 06/2012
3	Cyclin D1IBA 05/2005 - 12/2003
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2005 - 02/2003
2	4-azidobenzylcarazolol (pABC)IBA 01/2022 - 12/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020 - 01/2020
2	Formaldehyde (Formol)FDA Link 10/2019 - 08/2014
2	Estrogen Receptor alphaIBA 01/2018 - 01/2010
2	Delta CateninIBA 12/2016 - 08/2013
2	Single-Domain AntibodiesIBA 01/2016 - 04/2006
2	Insulin (Novolin)FDA Link 11/2013 - 06/2012
2	Growth Factor ReceptorsIBA 08/2013 - 01/2013
2	Tumor Biomarkers (Tumor Markers)IBA 07/2013 - 01/2013
2	carbonic anhydrase XIIIBA 07/2013 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2013 - 02/2003
2	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2012 - 12/2011
2	Hypoxia-Inducible Factor 1IBA 01/2008 - 01/2005
2	Cyclin AIBA 05/2005 - 01/2004
2	Cell Cycle ProteinsIBA 05/2005 - 01/2004
1	Tamoxifen FDA LinkGeneric 11/2021
1	Aromatase InhibitorsIBA 11/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2020
1	liposomal doxorubicin (Doxil)FDA Link 11/2020
1	insulin receptor-related receptor (IRR)IBA 10/2020
1	ORALIT (ORS)IBA 05/2020
1	UbiquitinIBA 01/2020
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020
1	BuffersIBA 01/2020
1	SOXC Transcription FactorsIBA 12/2018
1	Endothelin-1 (Endothelin 1)IBA 12/2018
1	Interleukin-6 (Interleukin 6)IBA 04/2018
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 04/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2017
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 03/2017
1	olaparibIBA 03/2017
1	Biological ProductsIBA 01/2017
1	DEAD-box RNA HelicasesIBA 09/2015
1	Connective Tissue Growth FactorIBA 01/2015
1	ClaudinsIBA 12/2014
1	Claudin-1IBA 12/2014
1	TNF Receptor-Associated Factor 4IBA 03/2014
1	CXC ChemokinesIBA 11/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 09/2013

Therapy/Procedure

21	Therapeutics 01/2022 - 04/2004
14	Drug Therapy (Chemotherapy) 01/2022 - 05/2003
9	Adjuvant Chemotherapy 01/2022 - 07/2004
6	Ligation 03/2018 - 01/2010
2	Aftercare (After-Treatment) 01/2019 - 11/2005
2	Computer-Assisted Surgery (Image Guided Surgery) 12/2016 - 07/2013
2	Neoadjuvant Therapy 08/2014 - 12/2009
2	Palliative Care (Palliative Therapy) 09/2013 - 03/2013
2	Lymph Node Excision (Lymph Node Dissection) 12/2009 - 11/2008
1	Induced Hyperthermia (Thermotherapy) 11/2020
1	Continuity of Patient Care 01/2019
1	Radiotherapy 03/2018
1	Prophylactic Mastectomy 09/2017
1	Salpingo-oophorectomy 09/2017